Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
DC Vaccine and CIK Cells in NSCLC with Bone Metastases
NCT02688686Phase 2Unknown
- Sponsor
- Academy of Military Medical Sciences
- Start
- Feb 2016
- Primary completion
- Feb 2018
- Modality
- Allogeneic CAR-T, Tumor-Infiltrating Lymphocytes (TILs), TCR-Engineered T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of unmodified CIK in non-small cell lung cancer (NSCLC), sponsored by Academy of Military Medical Sciences. Status: unknown.
02
Drugs
unmodified CIK
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NCT02688686.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02688686.